Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) reported Q4 CY2024 results , with sales up 10.5% year on year to $391.1 million. On the other hand, the company’s full-year revenue guidance of $1.

Lantheus Holdings Inc (LNTH) reports robust sales growth for PYLARIFY and DEFINITY, while navigating increased operating expenses and strategic investments.

We recently published a list of 15 Best Fast Growth Stocks To Buy Right Now. In this article, we are going to take a look at where Lantheus Holdings, Inc. (NASDAQ:LNTH) stands against other best fast growth stocks to buy right now.